Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates...
Pfizer Inc. and BioNTech SE announced that two of the companies’ four investigational vaccine candidates...
QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for...
QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical...
Zydus vaccine for COVID-19 (ZyCoV-D) successfully completes preclinical development and receives permission to initiate...
Zydus an innovation-driven, global pharmaceutical company, announced that it's plasmid DNA vaccine candidate for COVID-19...
ERT Continues to Drive Innovation in Virtualization for Respiratory Clinical Trials
ERT, the global leader in clinical endpoints data collection, announced a strategic partnership with Inofab...
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy...
Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced it has...
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea
Samsung Bioepis announced the initiation of Phase 3 clinical trial for SB15, the company's proposed...
Astrazeneca: Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
AstraZeneca announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the...
LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care,...
India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase...
Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the...
Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1 dual...
Zealand Pharma announced that the first patient has been dosed in a Phase 2 clinical...
